Transaction in Own Shares

RNS Number : 5088W
Stenprop Limited
19 August 2020
 

 

 

 

 

 

STENPROP LIMITED

(Registered in Guernsey)

(Registration number 64865)

LSE share code: STP  JSE share code: STP

ISIN:  GG00BFWMR296

("Stenprop" or the "Company")

 

TRANSACTION IN OWN SHARES

 

19 August 2020

 

Further to the announcement published on 3 July 2020 informing shareholders that the Company intended to repurchase shares to mitigate the dilutive effect of the scrip dividend election, shareholders are advised that on 18 August 2020, the Company purchased 310,204 ordinary shares at 117 pence per share. These shares will be held as treasury shares.

 

Following the above transaction, the total number of treasury shares held by the Company is 12,815,690 ordinary shares and the total number of shares in issue less shares held in treasury is 285,959,485 ordinary shares. From 18 August 2020, the total number of voting rights in the Company is 285,959,485.

 

 

For further information:

 

Stenprop Limited   +44(0)20 3918 6600

Paul Arenson (paul.arenson@stenprop.com)

Julian Carey (julian.carey@stenprop.com)  

James Beaumont (james.beaumont@stenprop.com)

   

 

Numis Securities Limited (Financial Adviser)      +44(0)20 7260 1000

Hugh Jonathan

Vicki Paine

Justin Bell 

 

FTI Consulting       +44(0)20 3 727 1000

Richard Sunderland  stenprop@fticonsulting.com

Richard Gotla

Indraneel Bose

 

Java Capital Trustees and Sponsors Proprietary Limited   +27 (0)11 722 3050

(JSE Sponsor)

 

About Stenprop:

 

Stenprop is a UK REIT listed on the LSE and the JSE. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to stenprop.com.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSUWOBRRKUWAAR
UK 100

Latest directors dealings